Skip to content

Clinical observation of extracorporeal shock wave in the treatment of elderly diabetic peripheral neuropathy

Clinical observation of extracorporeal shock wave in the treatment of elderly diabetic peripheral neuropathy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003997
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic peripheral neuropathy

Interventions

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Comply with "China Guidelines for Type 2 Diabetes Prevention and Treatment (2017 Edition)"; 2. Meet the diagnostic criteria of DPN in the "2013 Consensus on Diagnosis and Treatment of Diabetic Peripheral Neuropathy"; 3. Aged >= 60 years, no gender limit; 4. Use Toronto Clinical Neuropathy Score (TCSS) for preliminary screening, with a preliminary screening score of 6 to 11; 5. The patient signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Exclude peripheral neuropathy caused by other reasons; 2. Accompanied by serious primary diseases (such as cardiovascular, respiratory, digestive, endocrine, blood, metabolic and other system diseases); or patients with mental illness; or patients with malignant tumors. 3. Interrupted treatment and incomplete medical records.

Design outcomes

Primary

MeasureTime frame
EMG;Toronto Clinical Score;Visual analog scale;

Secondary

MeasureTime frame
Fasting blood glucose;Blood flow;Glycated hemoglobin;

Countries

China

Contacts

Public ContactWang Yuanyuan

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

molihh@163.com+86 18017546661

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026